🚀 VC round data is live in beta, check it out!
Innospec Valuation Multiples
Discover revenue and EBITDA valuation multiples for Innospec and similar public comparables like CAC Nantong Chemical Co, OQ Base Industries, Elkem, Saudi Chemical and more.
Innospec Overview
About Innospec
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
Founded
1998
HQ
Employees
2.5K
Website
Sectors
Financials (LTM)
EV
$2B
Innospec Financials
Innospec reported last 12-month revenue of $2B and EBITDA of $202M.
In the same LTM period, Innospec generated $496M in gross profit, $202M in EBITDA, and $118M in net income.
Revenue (LTM)
Innospec P&L
In the most recent fiscal year, Innospec reported revenue of $2B and EBITDA of $203M.
Innospec expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $496M | XXX | $492M | XXX | XXX | XXX |
| Gross Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| EBITDA | $202M | XXX | $203M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $118M | XXX | $117M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Innospec Stock Performance
Innospec has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Innospec's stock price is $77.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $4.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInnospec Valuation Multiples
Innospec trades at 0.9x EV/Revenue multiple, and 8.3x EV/EBITDA.
EV / Revenue (LTM)
Innospec Financial Valuation Multiples
As of March 17, 2026, Innospec has market cap of $2B and EV of $2B.
Equity research analysts estimate Innospec's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Innospec has a P/E ratio of 16.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 8.3x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 11.0x | XXX | 10.7x | XXX | XXX | XXX |
| EV/Gross Profit | 3.4x | XXX | 3.4x | XXX | XXX | XXX |
| P/E | 16.2x | XXX | 16.4x | XXX | XXX | XXX |
| EV/FCF | 26.1x | XXX | 26.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Innospec Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Innospec Margins & Growth Rates
Innospec's revenue in the last 12 month grew by 4%.
Innospec's revenue per employee in the last FY averaged $0.7M.
Innospec's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Innospec's rule of X is 22% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Innospec Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.7M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Innospec Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| CAC Nantong Chemical Co | XXX | XXX | XXX | XXX | XXX | XXX |
| OQ Base Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Elkem | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi Chemical | XXX | XXX | XXX | XXX | XXX | XXX |
| Alzchem Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Innospec M&A Activity
Innospec acquired XXX companies to date.
Last acquisition by Innospec was on XXXXXXXX, XXXXX. Innospec acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Innospec
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialInnospec Investment Activity
Innospec invested in XXX companies to date.
Innospec made its latest investment on XXXXXXXX, XXXXX. Innospec invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Innospec
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Innospec
| When was Innospec founded? | Innospec was founded in 1998. |
| Where is Innospec headquartered? | Innospec is headquartered in United States. |
| How many employees does Innospec have? | As of today, Innospec has over 2K employees. |
| Who is the CEO of Innospec? | Innospec's CEO is Patrick S. Williams. |
| Is Innospec publicly listed? | Yes, Innospec is a public company listed on Nasdaq. |
| What is the stock symbol of Innospec? | Innospec trades under IOSP ticker. |
| When did Innospec go public? | Innospec went public in 1998. |
| Who are competitors of Innospec? | Innospec main competitors are CAC Nantong Chemical Co, OQ Base Industries, Elkem, Saudi Chemical. |
| What is the current market cap of Innospec? | Innospec's current market cap is $2B. |
| What is the current revenue of Innospec? | Innospec's last 12 months revenue is $2B. |
| What is the current revenue growth of Innospec? | Innospec revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Innospec? | Current revenue multiple of Innospec is 0.9x. |
| Is Innospec profitable? | Yes, Innospec is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Innospec? | Innospec's last 12 months EBITDA is $202M. |
| What is Innospec's EBITDA margin? | Innospec's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Innospec? | Current EBITDA multiple of Innospec is 8.3x. |
| What is the current FCF of Innospec? | Innospec's last 12 months FCF is $64M. |
| What is Innospec's FCF margin? | Innospec's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Innospec? | Current FCF multiple of Innospec is 26.1x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.